TheEdgeResearch
Home / Stocks / ECS.AX

ECS Botanics Holdings Ltd (ECS.AX)

ASX Healthcare Drug Manufacturers - Specialty & Generic
$0.01 ▲ +0.00%
Market Cap
$8.0M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.60
52-Wk Range
0.003-0.01
CEO
Nan-Maree Schoerie Chem
Country
AU
Currency
AUD

ECS Botanics Holdings Ltd operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Launceston, TAS, AU. The stock last traded at $0.01, up 0.00% on the session, giving a market capitalisation of $8.0M. Its beta of 1.60 implies it has historically moved more than the broad market.

Company profile
Exchange
Australian Securities Exchange
Employees
220
IPO date
2000-01-02
Headquarters
Launceston, TAS, AU
About ECS Botanics Holdings Ltd

ECS Botanics Holdings Ltd specializes in the cultivation, processing, and commercialization of medicinal cannabis products. The enterprise also markets a variety of hemp-derived wellness and food items and is active in the agricultural sector. Its primary operations are headquartered in Launceston, Australia.

Comparable companies

ECS Botanics Holdings Ltd is most often compared with the following Healthcare names:

AGH.AXCAN.AXCHM.AXHIQ.AXICR.AXIME.AXIVX.AXIXC.AXPER.AXTRU.AX
More research on ECS.AX
ECS.AX technical analysis ECS.AX TheEdge Score Compare against peers
Open full interactive analysis & DCF →